Paper3045692
Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells.
Rodriguez M and 3 others. Neurology, 1988. Cited by 83 papers, by iCite.
Cite this record
ConductScience Library. Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells. Papers, record 3045692. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3045692
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoimmune Diseases | Major topic |
| Cerebellar Diseases | Major topic |
| Paraneoplastic Syndromes | Major topic |
| Purkinje Cells | Major topic |
| Aged | |
| Binding Sites | |
| Female | |
| Fluorescent Antibody Technique | |
| Humans |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-37343 | NCI NIH HHS | United States | R01CA037343 | PubMed and NIH | NIH RePORTER |
| NS-849 | NINDS NIH HHS | United States | PubMed | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40637585 | CDR2 is a dynein adaptor recruited by kinectin to regulate ER sheet organization. | J Cell Biol | 2025 | https://conductscience.org/library/papers/40637585 | PubMed |
| 39119541 | Paraneoplastic neurological syndromes of small cell lung cancer. | Postep Psychiatr Neurol | 2024 | https://conductscience.org/library/papers/39119541 | PubMed |
| 38802745 | Multi-omics profiling reveals dysregulated ribosome biogenesis and impaired cell proliferation following knockout of CDR2L. | BMC Cancer | 2024 | https://conductscience.org/library/papers/38802745 | PubMed |
| 38510211 | Cerebellar degeneration in gluten ataxia is linked to microglial activation. | Brain Commun | 2024 | https://conductscience.org/library/papers/38510211 | PubMed |
| 37239077 | Paraneoplastic Neurological Syndromes of the Central Nervous System: Pathophysiology, Diagnosis, and Treatment. | Biomedicines | 2023 | https://conductscience.org/library/papers/37239077 | PubMed |
| 35881322 | The Discovery of Anti-Yo (Anti-PCA1) Antibody in Patients with Paraneoplastic Cerebellar Degeneration: Opening a Window into Autoimmune Neurological Disease. | Cerebellum | 2023 | https://conductscience.org/library/papers/35881322 | PubMed |
| 35111121 | Paraneoplastic and Other Autoimmune Encephalitides: Antineuronal Antibodies, T Lymphocytes, and Questions of Pathogenesis. | Front Neurol | 2021 | https://conductscience.org/library/papers/35111121 | PubMed |
| 34277016 | Paraneoplastic neurological syndrome: an evolving story. | Neurooncol Pract | 2021 | https://conductscience.org/library/papers/34277016 | PubMed |
| 33009713 | Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration. | Ann Clin Transl Neurol | 2020 | https://conductscience.org/library/papers/33009713 | PubMed |
| 29930189 | Paraneoplastic cerebellar degeneration with bilateral facial palsy: a rare primary presentation of breast cancer. | BMJ Case Rep | 2018 | https://conductscience.org/library/papers/29930189 | PubMed |
| 29679372 | Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity. | Neuropathol Appl Neurobiol | 2019 | https://conductscience.org/library/papers/29679372 | PubMed |
| 27606347 | Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review. | Ann Clin Transl Neurol | 2016 | https://conductscience.org/library/papers/27606347 | PubMed |
| 26561982 | Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy. | Muscle Nerve | 2016 | https://conductscience.org/library/papers/26561982 | PubMed |
| 26377319 | 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook. | J Neuroinflammation | 2015 | https://conductscience.org/library/papers/26377319 | PubMed |
| 25885452 | Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers. | PLoS One | 2015 | https://conductscience.org/library/papers/25885452 | PubMed |
| 25341622 | Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis. | Acta Neuropathol | 2014 | https://conductscience.org/library/papers/25341622 | PubMed |
| 24167748 | Anti-yo associated paraneoplastic cerebellar degeneration in a man with large cell cancer of the lung. | Case Rep Neurol Med | 2013 | https://conductscience.org/library/papers/24167748 | PubMed |
| 22934121 | Anti-purkinje cell and natural autoantibodies in a group of psychiatric patients. Evidences for a correlation with the psychopathological status. | Clin Pract Epidemiol Ment Health | 2012 | https://conductscience.org/library/papers/22934121 | PubMed |
| 20838245 | Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures. | J Neuropathol Exp Neurol | 2010 | https://conductscience.org/library/papers/20838245 | PubMed |
| 10219744 | Autoimmunity in paraneoplastic neurological syndromes. | Brain Pathol | 1999 | https://conductscience.org/library/papers/10219744 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3045692
GET https://conductscience.org/api/papers/v1/3045692/cited_by?page=2